TARO PHARMACEUTICAL INDUS (TARO)
IL0010827181 - Common Stock
| TTM (2023-12-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | 2021 (2021-3-31) | 2020 (2020-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 45.69M | 25.40M | 58.30M | -400.70M | 244.60M | |||
| Depreciation Amortization | 33.67M | 32.10M | 25.90M | 23.70M | 21.40M | |||
| Income Taxes - Deferred | 17.39M | 16.80M | 23.20M | -38.40M | 7.60M | |||
| Change In Working Capital | 50.95M | -53.20M | -279.00M | 460.70M | 10.60M | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Taxes Paid | -29.93M | -10.00M | 5.40M | 33.50M | 30.20M | |||
| Other non cash items | -4.78M | 10.60M | 12.90M | 600.00K | -12.60M | |||
| OPERATING CASH FLOW | 142.92M | 31.80M | -158.70M | 45.80M | 271.60M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -56.83M | -19.80M | -111.30M | -17.20M | -28.40M | |||
| Other Investing Activity | N/A | -105.70M | -59.30M | 84.90M | -269.70M | |||
| INVESTING CASH FLOW | 148.14M | -125.60M | -170.60M | 67.70M | -298.20M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | N/A | 0.00 | -24.90M | -24.20M | -27.00M | |||
| Dividend Paid | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Other Financing Activity | N/A | 0.00 | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | N/A | 0.00 | -24.90M | -24.20M | -27.00M | |||
| Exchange Rate Effect | -643.00K | -2.80M | 200.00K | 2.50M | -600.00K | |||
| CHANGE IN CASH | 290.41M | -96.60M | -354.00M | 91.80M | -54.20M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 142.92M | 31.80M | -158.70M | 45.80M | 271.60M | |||
| Capital Expenditure | -56.83M | -19.80M | -111.30M | -17.20M | -28.40M | |||
| FREE CASH FLOW | 86.09M | 12.00M | -270.00M | 28.60M | 243.20M | |||
All data in USD